Back to search

Article

Development and implementation of site-specific Hepatitis C Virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study, a prospective single-arm intervention trial

2023-02-15

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Hepatitis C virus (HCV) is the leading indication for liver transplantation and liver-related mortality. The development of direct acting antivirals (DAA) and a simplified treatment algorithm with a >97% cure rate should make global elimination of HCV an achievable goal. Yet, vulnerable populations with high rates of HCV still have limited access to treatment. B...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
92b9aa2c-658d-510a-9a06-c787c8a3213c
DOI
10.21203/rs.3.rs-2399039/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development and implementation of site-specific Hepatitis C Virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study, a prospective single-arm intervention trialDOI 10.21203/rs.3.rs-2399039/v1
Select a neighboring publication to make it the new centre.